Max Sakajja

Max Sakajja has extensive experience in the pharmaceutical and life science industry. Currently serving as Vice President International Markets at Hansa Biopharma, Max is responsible for commercial partnerships, execution, and sales in various international regions. Prior to this role, Max held positions such as Global Product and Service Development Manager at Envirotainer and Mergers & Acquisitions Director at Sobi. With a background in Molecular Biotechnology, Max has also founded Enzymus | Life Science Partners and has experience in corporate development, financing, and market analysis.